| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Ralph A. DeFronzo | Q58689309 |
| P2093 | author name string | Muhammad A Abdul-Ghani | |
| P2860 | cites work | Increased rates of fatty acid uptake and plasmalemmal fatty acid transporters in obese Zucker rats | Q74371834 |
| Defective regulation of phosphatidylinositol-3-kinase gene expression in skeletal muscle and adipose tissue of non-insulin-dependent diabetes mellitus patients | Q74651679 | ||
| Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade | Q77795070 | ||
| Muscular long-chain fatty acid content during graded exercise in humans | Q78020167 | ||
| Muscle-specific overexpression of FAT/CD36 enhances fatty acid oxidation by contracting muscle, reduces plasma triglycerides and fatty acids, and increases plasma glucose and insulin | Q78239684 | ||
| A short-term, high-fat diet up-regulates lipid metabolism and gene expression in human skeletal muscle | Q78829955 | ||
| Skeletal muscle mitochondrial functions, mitochondrial DNA copy numbers, and gene transcript profiles in type 2 diabetic and nondiabetic subjects at equal levels of low or high insulin and euglycemia | Q79386766 | ||
| Organizing glucose disposal: emerging roles of the glycogen targeting subunits of protein phosphatase-1 | Q22255448 | ||
| Insulin signalling and the regulation of glucose and lipid metabolism | Q24292020 | ||
| Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose | Q24299251 | ||
| Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance | Q24629603 | ||
| Analysis of the gene sequences of the insulin receptor and the insulin-sensitive glucose transporter (GLUT-4) in patients with common-type non-insulin-dependent diabetes mellitus | Q24630675 | ||
| Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction | Q24632414 | ||
| Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1 | Q24679555 | ||
| Decreased insulin-stimulated ATP synthesis and phosphate transport in muscle of insulin-resistant offspring of type 2 diabetic parents | Q24812499 | ||
| The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus | Q28190307 | ||
| Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha | Q28274682 | ||
| Skeletal muscle lipid metabolism in exercise and insulin resistance | Q28288218 | ||
| Molecular biology of mammalian glucose transporters | Q28299428 | ||
| Cloning of a human insulin-stimulated protein kinase (ISPK-1) gene and analysis of coding regions and mRNA levels of the ISPK-1 and the protein phosphatase-1 genes in muscle from NIDDM patients | Q28304988 | ||
| Molecular scanning of insulin-responsive glucose transporter (GLUT4) gene in NIDDM subjects | Q28306232 | ||
| Impaired activation of glycogen synthase in people at increased risk for developing NIDDM | Q28319557 | ||
| Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes | Q28369463 | ||
| The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity | Q28506782 | ||
| Mitochondrial dysfunction, insulin resistance, and type 2 diabetes mellitus | Q37215415 | ||
| Ectopic fat and insulin resistance | Q37215424 | ||
| Glucose metabolism and insulin resistance in sepsis | Q37239839 | ||
| Mitochondrial dysfunction in type 2 diabetes and obesity | Q37262315 | ||
| Insulin-stimulated translocation of glucose transporter (GLUT) 12 parallels that of GLUT4 in normal muscle | Q37341858 | ||
| HIV protease inhibitors and insulin resistance: lessons from in-vitro, rodent and healthy human volunteer models | Q37447923 | ||
| Reduced glycogen synthase activity in skeletal muscle from obese patients with and without type 2 (non-insulin-dependent) diabetes mellitus. | Q54299084 | ||
| Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. | Q54332121 | ||
| Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. | Q55033199 | ||
| Skeletal muscle substrate utilization during submaximal exercise in man: effect of endurance training. | Q55066073 | ||
| Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM. | Q55066500 | ||
| High-fat diet, muscular lipotoxicity and insulin resistance | Q55162956 | ||
| Identification of four amino acid substitutions in hexokinase II and studies of relationships to NIDDM, glucose effectiveness, and insulin sensitivity | Q57737459 | ||
| Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients | Q58449883 | ||
| Lipid Infusion Decreases the Expression of Nuclear Encoded Mitochondrial Genes and Increases the Expression of Extracellular Matrix Genes in Human Skeletal Muscle | Q58451168 | ||
| The molecular mechanism by which insulin stimulates glycogen synthesis in mammalian skeletal muscle | Q59069709 | ||
| Regulation of hexokinase II expression in human skeletal muscle in vivo | Q60526210 | ||
| Insulin-induced hexokinase II expression is reduced in obesity and NIDDM | Q60526216 | ||
| Mitochondrial Respiration Is Decreased in Skeletal Muscle of Patients With Type 2 Diabetes | Q62603232 | ||
| Plasmalemmal fatty acid transport is regulated in heart and skeletal muscle by contraction, insulin and leptin, and in obesity and diabetes | Q63805190 | ||
| Insulin receptor substrate-1 gene mutations in NIDDM; implications for the study of polygenic disease | Q63916586 | ||
| Insulin resistance in essential hypertension | Q68164220 | ||
| Glucose storage is a major determinant of in vivo "insulin resistance" in subjects with normal glucose tolerance | Q68866015 | ||
| Normal insulin-receptor cDNA sequence in Pima Indians with NIDDM | Q69440207 | ||
| Defects in insulin-receptor internalization and processing in monocytes of obese subjects and obese NIDDM patients | Q69554764 | ||
| Human insulin receptors mutated at the ATP-binding site lack protein tyrosine kinase activity and fail to mediate postreceptor effects of insulin | Q70322324 | ||
| Insulin secretion, insulin resistance, and obesity | Q71439402 | ||
| The effect of graded doses of insulin on total glucose uptake, glucose oxidation, and glucose storage in man | Q71462701 | ||
| Regulation of hexokinase II and glycogen synthase mRNA, protein, and activity in human muscle | Q71553004 | ||
| Kinetic analysis of the oxidation of palmitate-1-14C in man during prolonged heavy muscular exercise | Q72240517 | ||
| Alterations in the expression and cellular localization of protein kinase C isozymes epsilon and theta are associated with insulin resistance in skeletal muscle of the high-fat-fed rat | Q72989982 | ||
| Chronic leptin administration decreases fatty acid uptake and fatty acid transporters in rat skeletal muscle | Q28572981 | ||
| Human hexokinase II gene: exon-intron organization, mutation screening in NIDDM, and its relationship to muscle hexokinase activity | Q28637792 | ||
| Banting lecture 1988. Role of insulin resistance in human disease | Q29547283 | ||
| Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes | Q29614548 | ||
| Mechanisms linking obesity to insulin resistance and type 2 diabetes | Q29614887 | ||
| Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes | Q29616567 | ||
| Mitochondrial dysfunction and type 2 diabetes | Q29617913 | ||
| Mitochondrial dysfunction in the elderly: possible role in insulin resistance | Q29618783 | ||
| Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects. | Q31075599 | ||
| Muscle mitochondrial ATP synthesis and glucose transport/phosphorylation in type 2 diabetes | Q33283340 | ||
| Effect of short-term free Fatty acids elevation on mitochondrial function in skeletal muscle of healthy individuals | Q33586726 | ||
| Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance | Q33588931 | ||
| The Croonian Lecture 1998. Identification of a protein kinase cascade of major importance in insulin signal transduction | Q33599031 | ||
| Glucose transporters and insulin action--implications for insulin resistance and diabetes mellitus | Q33691309 | ||
| Insulin signaling in the arterial wall | Q33694779 | ||
| Membrane proteins implicated in long-chain fatty acid uptake by mammalian cells: CD36, FATP and FABPm | Q33753937 | ||
| Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity | Q33834971 | ||
| Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes | Q33853693 | ||
| Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats | Q33857313 | ||
| Signalling through the insulin receptor | Q33860499 | ||
| Characterization of cellular defects of insulin action in type 2 (non-insulin-dependent) diabetes mellitus | Q33889791 | ||
| Regulation of phosphatidylinositol 3-kinase activity in liver and muscle of animal models of insulin-resistant and insulin-deficient diabetes mellitus | Q33904740 | ||
| Signaling pathways in insulin action: molecular targets of insulin resistance | Q33973814 | ||
| Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion | Q34106543 | ||
| Transmembrane glucose transport in skeletal muscle of patients with non-insulin-dependent diabetes | Q34114343 | ||
| Nomenclature of the GLUT/SLC2A family of sugar/polyol transport facilitators. | Q34117304 | ||
| Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents. | Q34126257 | ||
| Studies on the mechanism of insulin resistance in the liver from humans with noninsulin-dependent diabetes. Insulin action and binding in isolated hepatocytes, insulin receptor structure, and kinase activity | Q34182065 | ||
| Intracellular glucose oxidation and glycogen synthase activity are reduced in non-insulin-dependent (type II) diabetes independent of impaired glucose uptake | Q34243161 | ||
| Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach | Q34294997 | ||
| Molecular and linkage analysis of type-1 protein phosphatase catalytic beta-subunit gene: lack of evidence for its major role in insulin resistance in Pima Indians | Q34314399 | ||
| Impaired mitochondrial substrate oxidation in muscle of insulin-resistant offspring of type 2 diabetic patients | Q34370850 | ||
| GSK3 takes centre stage more than 20 years after its discovery | Q34374129 | ||
| Demonstration of insulin resistance in untreated adult onset diabetic subjects with fasting hyperglycemia | Q34474718 | ||
| Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus | Q34541876 | ||
| Diabetes trends in the U.S.: 1990-1998. | Q44590624 | ||
| Discordant effects of a chronic physiological increase in plasma FFA on insulin signaling in healthy subjects with or without a family history of type 2 diabetes | Q44883028 | ||
| Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36. | Q44888045 | ||
| Regulation of plasma long-chain fatty acid oxidation in relation to uptake in human skeletal muscle during exercise | Q44928887 | ||
| Intracellular defects in glucose metabolism in obese patients with NIDDM. | Q45156124 | ||
| Glucose Intolerance and Aging: Evidence for Tissue Insensitivity to Insulin | Q45186876 | ||
| Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes | Q45199109 | ||
| Additive effects of insulin and muscle contraction on fatty acid transport and fatty acid transporters, FAT/CD36, FABPpm, FATP1, 4 and 6. | Q45968554 | ||
| Role of human skeletal muscle insulin receptor kinase in the in vivo insulin resistance of noninsulin-dependent diabetes mellitus and obesity. | Q46017837 | ||
| Prospective investigation of metabolic characteristics in relation to weight gain in older adults: the Hoorn Study | Q46131438 | ||
| Dose-response effect of elevated plasma free fatty acid on insulin signaling | Q46513253 | ||
| Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. | Q46624327 | ||
| Insulin sensitivity in African-American children with and without family history of type 2 diabetes | Q46674629 | ||
| Effect of a sustained reduction in plasma free fatty acid concentration on intramuscular long-chain fatty Acyl-CoAs and insulin action in type 2 diabetic patients | Q46774705 | ||
| Development of hyperinsulinemia and insulin resistance during the early stage of weight gain | Q46825836 | ||
| Impact of exercise training on insulin sensitivity, physical fitness, and muscle oxidative capacity in first-degree relatives of type 2 diabetic patients | Q46849852 | ||
| Increased lipid availability impairs insulin-stimulated ATP synthesis in human skeletal muscle | Q46870183 | ||
| Decreased non-insulin-dependent glucose clearance contributes to the rise in fasting plasma glucose in the nondiabetic range | Q46901912 | ||
| Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes | Q46915798 | ||
| Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss | Q47251032 | ||
| Changes induced by physical activity and weight loss in the morphology of intermyofibrillar mitochondria in obese men and women | Q47338109 | ||
| Effects of weight loss and physical activity on skeletal muscle mitochondrial function in obesity | Q47398932 | ||
| Genetic variants in promoters and coding regions of the muscle glycogen synthase and the insulin-responsive GLUT4 genes in NIDDM. | Q48080300 | ||
| An electrophoretic study of the distribution and properties of human hexokinases | Q48426127 | ||
| Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects. | Q51561168 | ||
| A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. | Q51562671 | ||
| Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. | Q51565080 | ||
| Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure. | Q51574264 | ||
| Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study. | Q51575337 | ||
| Skeletal muscle triglyceride levels are inversely related to insulin action. | Q51575343 | ||
| Insulin resistance and coronary artery disease. | Q51578743 | ||
| Insulin action on glucose transport and plasma membrane GLUT4 content in skeletal muscle from patients with NIDDM. | Q51579259 | ||
| Intramuscular triglyceride and muscle insulin sensitivity: evidence for a relationship in nondiabetic subjects. | Q51580403 | ||
| Elevation of serum insulin concentration during euglycemic hyperinsulinemic clamp studies leads to similar activation of insulin receptor kinase in skeletal muscle of subjects with and without NIDDM. | Q51584932 | ||
| Tissue oxidative capacity, fuel stores and skeletal muscle fatty acid composition in obesity-prone and obesity-resistant rats. | Q51586048 | ||
| The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents | Q51603248 | ||
| Effect of insulin on oxidative and nonoxidative pathways of free fatty acid metabolism in human obesity. | Q51604953 | ||
| Skeletal muscle glycogen synthase activity in subjects with non-insulin-dependent diabetes mellitus after glyburide therapy. | Q51613792 | ||
| Oxidative and non-oxidative glucose metabolism in non-obese type 2 (non-insulin-dependent) diabetic patients. | Q51624905 | ||
| Human Forearm Muscle Metabolism during Exercise II Uptake, release and oxidation of individual FFA and glycerol | Q53023760 | ||
| Insulin action and insulin resistance: diseases involving defects in insulin receptors, signal transduction, and the glucose transport effector system. | Q54117527 | ||
| Reversal of chronic alterations of skeletal muscle protein kinase C from fat-fed rats by BRL-49653. | Q54151747 | ||
| Polymorphisms of the human hexokinase II gene: lack of association with NIDDM and insulin resistance. | Q54174859 | ||
| Insulin resistance in type 2 (non-insulin-dependent) diabetic patients and their relatives is not associated with a defect in the expression of the insulin-responsive glucose transporter (GLUT-4) gene in human skeletal muscle | Q54276480 | ||
| Impaired expression of glycogen synthase mRNA in skeletal muscle of NIDDM patients. | Q54284119 | ||
| Cellular mechanisms of insulin resistance: role of stress-regulated serine kinases and insulin receptor substrates (IRS) serine phosphorylation | Q37580452 | ||
| Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease | Q37742798 | ||
| Modest PGC-1alpha overexpression in muscle in vivo is sufficient to increase insulin sensitivity and palmitate oxidation in subsarcolemmal, not intermyofibrillar, mitochondria | Q38295319 | ||
| Metabolism of Free Fatty Acids and Ketone Bodies During Exercise in Normal and Diabetic Man | Q39644506 | ||
| Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. | Q39648063 | ||
| Adaptations of skeletal muscle to endurance exercise and their metabolic consequences | Q40178125 | ||
| Mitochondrial dysfunction induces aberrant insulin signalling and glucose utilisation in murine C2C12 myotube cells | Q40273568 | ||
| Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus | Q40342100 | ||
| Effect of the antilipolytic nicotinic acid analogue acipimox on whole-body and skeletal muscle glucose metabolism in patients with non-insulin-dependent diabetes mellitus | Q40342372 | ||
| Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. | Q40452210 | ||
| Arachidonic acid and free fatty acids as second messengers and the role of protein kinase C | Q40475595 | ||
| Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus | Q41019246 | ||
| The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus | Q41176971 | ||
| Analysis of the signaling pathway involved in the regulation of hexokinase II gene transcription by insulin | Q41185163 | ||
| Evidence against altered expression of GLUT1 or GLUT4 in skeletal muscle of patients with obesity or NIDDM. | Q41232527 | ||
| Mitogen-activated protein kinase kinase inhibition does not block the stimulation of glucose utilization by insulin | Q41302003 | ||
| Carbohydrate and lipid metabolism of skeletal muscle in type 2 diabetic patients | Q41357348 | ||
| The inhibition of glycogen synthase kinase-3 by insulin or insulin-like growth factor 1 in the rat skeletal muscle cell line L6 is blocked by wortmannin, but not by rapamycin: evidence that wortmannin blocks activation of the mitogen-activated prote | Q41437636 | ||
| Troglitazone prevents glucose-induced insulin resistance of insulin receptor in rat-1 fibroblasts | Q41486246 | ||
| Insulin binding in diabetes. Relationships with plasma insulin levels and insulin sensitivity | Q41964676 | ||
| Lower intrinsic ADP-stimulated mitochondrial respiration underlies in vivo mitochondrial dysfunction in muscle of male type 2 diabetic patients | Q42439774 | ||
| Insulin Binding and Responsiveness in Fat Cells from Patients with Reduced Glucose Tolerance and Type II Diabetes | Q42454831 | ||
| Expression and function of IRS-1 in insulin signal transmission. | Q42455127 | ||
| Sustained reduction in plasma free fatty acid concentration improves insulin action without altering plasma adipocytokine levels in subjects with strong family history of type 2 diabetes | Q42467298 | ||
| Chronic kidney disease causes defects in signaling through the insulin receptor substrate/phosphatidylinositol 3-kinase/Akt pathway: implications for muscle atrophy | Q42493294 | ||
| Glucose uptake and metabolism by cultured human skeletal muscle cells: rate-limiting steps | Q42505768 | ||
| Adipocyte glycogen synthase and pyruvate dehydrogenase in obese and type II diabetic subjects | Q42511444 | ||
| Association of the glycogen synthase locus on 19q13 with NIDDM in Pima Indians | Q42520400 | ||
| Does impaired mitochondrial function affect insulin signaling and action in cultured human skeletal muscle cells? | Q42520636 | ||
| Differential effect of chronic treatment with two beta-blocking agents on insulin sensitivity: the carvedilol-metoprolol study | Q42554675 | ||
| Human hexokinase II mRNA and gene structure | Q42691343 | ||
| Localization of adipocyte long-chain fatty acyl-CoA synthetase at the plasma membrane. | Q42816411 | ||
| Insulin stimulation of glycogen synthesis and glycogen synthase activity is blocked by wortmannin and rapamycin in 3T3-L1 adipocytes: evidence for the involvement of phosphoinositide 3-kinase and p70 ribosomal protein-S6 kinase | Q42823635 | ||
| Hyperinsulinemia in nonobese women reporting a moderate weight gain at the beginning of menopause: a useful early measure of susceptibility to insulin resistance | Q43278211 | ||
| Large energetic adaptations of elderly muscle to resistance and endurance training | Q43572818 | ||
| Regulation by insulin of gene expression in human skeletal muscle and adipose tissue. Evidence for specific defects in type 2 diabetes. | Q43596031 | ||
| Increased fatty acid uptake and altered fatty acid metabolism in insulin-resistant muscle of obese Zucker rats | Q43618939 | ||
| Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects | Q43651825 | ||
| Interactions of impaired glucose transport and phosphorylation in skeletal muscle insulin resistance: a dose-response assessment using positron emission tomography | Q43719966 | ||
| Skeletal muscle insulin resistance in normoglycemic subjects with a strong family history of type 2 diabetes is associated with decreased insulin-stimulated insulin receptor substrate-1 tyrosine phosphorylation | Q43778798 | ||
| Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes | Q43833528 | ||
| The effect of concurrent endurance and strength training on quantitative estimates of subsarcolemmal and intermyofibrillar mitochondria | Q43843917 | ||
| Normalization of plasma glucose concentration by insulin therapy improves insulin-stimulated glycogen synthesis in type 2 diabetes | Q43867562 | ||
| Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle | Q43990155 | ||
| Evaluation of insulin resistance and metabolic syndrome in patients with polycystic ovary syndrome. | Q44002285 | ||
| Force generation, but not myosin ATPase activity, declines with age in rat muscle fibers | Q44021411 | ||
| Leptin increases FA oxidation in lean but not obese human skeletal muscle: evidence of peripheral leptin resistance | Q44030261 | ||
| Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha | Q44043178 | ||
| Free fatty acid-induced hepatic insulin resistance: a potential role for protein kinase C-delta | Q44129305 | ||
| Contribution of abnormal muscle and liver glucose metabolism to postprandial hyperglycemia in NIDDM. | Q44216727 | ||
| Skeletal muscle lipid metabolism with obesity | Q44355154 | ||
| Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes | Q44480693 | ||
| Impact of aerobic exercise training on age-related changes in insulin sensitivity and muscle oxidative capacity | Q44527020 | ||
| Enhanced fat oxidation through physical activity is associated with improvements in insulin sensitivity in obesity | Q44563999 | ||
| Decreased kinase activity of insulin receptors from adipocytes of non-insulin-dependent diabetic subjects | Q34556125 | ||
| Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes | Q34570368 | ||
| Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance | Q34577169 | ||
| Relationship between obesity and maximal insulin-stimulated glucose uptake in vivo and in vitro in Pima Indians | Q34605902 | ||
| Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus | Q34669998 | ||
| Influence of dietary fat composition on development of insulin resistance in rats. Relationship to muscle triglyceride and omega-3 fatty acids in muscle phospholipid | Q35013075 | ||
| Metabolic and molecular basis of insulin resistance | Q35148800 | ||
| Energy translocation across cell membranes and membrane models | Q35178592 | ||
| Regulation of glycogen synthase and phosphorylase activities by glucose and insulin in human skeletal muscle | Q35575530 | ||
| Effects of insulin infusion on human skeletal muscle pyruvate dehydrogenase, phosphofructokinase, and glycogen synthase. Evidence for their role in oxidative and nonoxidative glucose metabolism | Q35578164 | ||
| Role of glucose transporters in the cellular insulin resistance of type II non-insulin-dependent diabetes mellitus | Q35588279 | ||
| Reversibility of defective adipocyte insulin receptor kinase activity in non-insulin-dependent diabetes mellitus. Effect of weight loss | Q35591970 | ||
| Glycogen synthase and phosphofructokinase protein and mRNA levels in skeletal muscle from insulin-resistant patients with non-insulin-dependent diabetes mellitus. | Q35609877 | ||
| Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle | Q35676919 | ||
| The role of lipid accumulation in liver and muscle for insulin resistance and type 2 diabetes mellitus in humans | Q35711963 | ||
| Effects of fat on glucose uptake and utilization in patients with non-insulin-dependent diabetes | Q35762624 | ||
| Studies of plasma membrane fatty acid-binding protein and other lipid-binding proteins in human skeletal muscle | Q35855930 | ||
| Pathogenesis of type 2 diabetes mellitus | Q35861736 | ||
| Metabolic fluxes in skeletal muscle in relation to obesity and insulin resistance | Q36252474 | ||
| Muscle triglycerides and mitochondrial function: possible mechanisms for the development of type 2 diabetes | Q36356864 | ||
| Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. | Q36401757 | ||
| Lipodystrophy: lessons in lipid and energy metabolism | Q36419149 | ||
| Etiology of insulin resistance | Q36431215 | ||
| Pathways leading to muscle insulin resistance--the muscle--fat connection | Q36576544 | ||
| Isolation and Characterization of the Human Muscle Glycogen Synthase Gene | Q36692469 | ||
| Muscle-specific IRS-1 Ser->Ala transgenic mice are protected from fat-induced insulin resistance in skeletal muscle | Q36906334 | ||
| Insulin signaling and glucose transport in insulin resistant human skeletal muscle | Q36914873 | ||
| In vitro insulin resistance of human adipocytes isolated from subjects with noninsulin-dependent diabetes mellitus | Q36991208 | ||
| An in vivo and in vitro study of the mechanism of prednisone-induced insulin resistance in healthy subjects | Q36992538 | ||
| Insulin Binding to Monocytes and Insulin Action in Human Obesity, Starvation, and Refeeding | Q37030221 | ||
| Insulin Sensitivity and Insulin Binding to Monocytes in Maturity-Onset Diabetes | Q37038173 | ||
| Molecular mechanisms of skeletal muscle insulin resistance in type 2 diabetes. | Q37065529 | ||
| Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus | Q37141727 | ||
| Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle | Q37175187 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | pathogenesis | Q372016 |
| human musculoskeletal system | Q726543 | ||
| tissue | Q40397 | ||
| insulin resistance | Q1053470 | ||
| preproinsulin | Q7240673 | ||
| physiological phenomenon | Q66615932 | ||
| P304 | page(s) | 476279 | |
| P577 | publication date | 2010-04-26 | |
| P1433 | published in | Journal of Biomedicine and Biotechnology | Q15752146 |
| P1476 | title | Pathogenesis of insulin resistance in skeletal muscle | |
| P478 | volume | 2010 |
| Q92025092 | 17Beta-estradiol Stimulates Glucose Uptake Through Estrogen Receptor and AMP-activated Protein Kinase Activation in C2C12 Myotubes (Korean J Obes 2016;25:190-6) |
| Q48174340 | 5-aminolevulinic acid (ALA) deficiency causes impaired glucose tolerance and insulin resistance coincident with an attenuation of mitochondrial function in aged mice. |
| Q35643225 | A higher-carbohydrate, lower-fat diet reduces fasting glucose concentration and improves β-cell function in individuals with impaired fasting glucose |
| Q38292347 | A novel hepatokine, HFREP1, plays a crucial role in the development of insulin resistance and type 2 diabetes |
| Q37714157 | AJS1669, a novel small-molecule muscle glycogen synthase activator, improves glucose metabolism and reduces body fat mass in mice |
| Q51280109 | AMP-activated protein kinase-mediated expression of heat shock protein beta 1 enhanced insulin sensitivity in the skeletal muscle. |
| Q35799511 | Abdominal fat depots associated with insulin resistance and metabolic syndrome risk factors in black African young adults |
| Q54943598 | Adipocyte-Derived Exosomal MiR-27a Induces Insulin Resistance in Skeletal Muscle Through Repression of PPARγ. |
| Q40512963 | Adipogenic progenitors from obese human skeletal muscle give rise to functional white adipocytes that contribute to insulin resistance. |
| Q38992920 | Altered amyloid precursor protein processing regulates glucose uptake and oxidation in cultured rodent myotubes. |
| Q35131396 | Altered fetal skeletal muscle nutrient metabolism following an adverse in utero environment and the modulation of later life insulin sensitivity. |
| Q89070136 | Altered tricarboxylic acid cycle flux in primary myotubes from severely obese humans |
| Q34168107 | An overview of the identification and management of the metabolic syndrome in chiropractic practice |
| Q40877016 | Anti-Diabetic Effect of Pectinase-Processed Ginseng Radix (GINST) in High Fat Diet-Fed ICR Mice |
| Q36022058 | Antihyperglycemic Activity of Eucalyptus tereticornis in Insulin-Resistant Cells and a Nutritional Model of Diabetic Mice |
| Q89715622 | Antipsychotic Medications and DNA Methylation in Schizophrenia and Bipolar Disorder: A Systematic Review |
| Q38838596 | Application of the integrated glucose-insulin model for cross-study characterization of T2DM patients on metformin background treatment |
| Q99708919 | Are Alterations in Skeletal Muscle Mitochondria a Cause or Consequence of Insulin Resistance? |
| Q90398294 | Association between metabolic syndrome and limb muscle quantity and quality in older adults: a pilot ultrasound study |
| Q89819445 | Association between non-obesity and health state among young Japanese male university students |
| Q51246446 | Association of Protein Kinase B (AKT) DNA Hypermethylation with Maintenance Atypical Antipsychotic Treatment in Patients with Bipolar Disorder. |
| Q57469245 | Atypical Antipsychotics and the Human Skeletal Muscle Lipidome |
| Q59607619 | Autotaxin-LPA signaling contributes to obesity-induced insulin resistance in muscle and impairs mitochondrial metabolism |
| Q41817975 | Beneficial effects of Ginkgo biloba extract on insulin signaling cascade, dyslipidemia, and body adiposity of diet-induced obese rats. |
| Q34533861 | Bioactives from Artemisia dracunculus L. enhance insulin sensitivity via modulation of skeletal muscle protein phosphorylation |
| Q37371324 | Biochemical adaptations of mammalian hibernation: exploring squirrels as a perspective model for naturally induced reversible insulin resistance. |
| Q27012801 | Brain insulin resistance in Alzheimer's disease and its potential treatment with GLP-1 analogs |
| Q57727148 | C-Peptides for diagnostics and therapy: a veterinary medicine point of view |
| Q28573833 | Caffeine modulates phosphorylation of insulin receptor substrate-1 and impairs insulin signal transduction in rat skeletal muscle |
| Q33959764 | Chronic reduction of plasma free fatty acid improves mitochondrial function and whole-body insulin sensitivity in obese and type 2 diabetic individuals |
| Q36163897 | Co-activator binding protein PIMT mediates TNF-α induced insulin resistance in skeletal muscle via the transcriptional down-regulation of MEF2A and GLUT4. |
| Q89621018 | Continuous Light-Induced PCOS-Like Changes in Reproduction, Metabolism, and Gut Microbiota in Sprague-Dawley Rats |
| Q37606197 | Contribution of the serine kinase c-Jun N-terminal kinase (JNK) to oxidant-induced insulin resistance in isolated rat skeletal muscle |
| Q38871530 | Curcumin and insulin resistance-Molecular targets and clinical evidences. |
| Q38603765 | Defects in skeletal muscle subsarcolemmal mitochondria in a non-obese model of type 2 diabetes mellitus. |
| Q52351080 | Dehydroepiandrosterone-induced activation of mTORC1 and inhibition of autophagy contribute to skeletal muscle insulin resistance in a mouse model of polycystic ovary syndrome. |
| Q47551711 | Deletion of Nrip1 extends female mice longevity, increases autophagy, and delays cell senescence |
| Q35858095 | Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline |
| Q37249009 | Developmental programming in skeletal muscle in response to overnourishment in the immediate postnatal life in rats |
| Q35785215 | Diabetes-Related Ankyrin Repeat Protein (DARP/Ankrd23) Modifies Glucose Homeostasis by Modulating AMPK Activity in Skeletal Muscle |
| Q64999482 | Dietary Patterns, Skeletal Muscle Health, and Sarcopenia in Older Adults. |
| Q50091317 | Dose-response effects of exercise on insulin among colon cancer survivors. |
| Q37604583 | Downregulation of lipin-1 induces insulin resistance by increasing intracellular ceramide accumulation in C2C12 myotubes |
| Q46062044 | Doxorubicin leads to impaired insulin signaling in skeletal muscle. |
| Q42517397 | Early metabolic defects in Arab subjects with strong family history of Type 2 diabetes. |
| Q47114679 | Early-onset and classical forms of type 2 diabetes show impaired expression of genes involved in muscle branched-chain amino acids metabolism |
| Q50988477 | Effects of Calorie Restriction and Fiber Type on Glucose Uptake and Abundance of Electron Transport Chain and Oxidative Phosphorylation Proteins in Single Fibers from Old Rats. |
| Q34023559 | Effects of exercise training on mitochondrial function in patients with type 2 diabetes. |
| Q58756544 | Effects of four weeks intermittent hypoxia intervention on glucose homeostasis, insulin sensitivity, GLUT4 translocation, insulin receptor phosphorylation, and Akt activity in skeletal muscle of obese mice with type 2 diabetes |
| Q35939148 | Effects of phenolic-rich extracts of Clinacanthus nutans on high fat and high cholesterol diet-induced insulin resistance. |
| Q47237475 | Effects of topical capsaicin combined with moderate exercise on insulin resistance, body weight and oxidative stress in hypoestrogenic obese rats. |
| Q84690618 | Effects of vitamin D treatment on skeletal muscle histology and ultrastructural changes in a rodent model |
| Q35821225 | Endoplasmic Reticulum Stress-Associated Lipid Droplet Formation and Type II Diabetes |
| Q38924286 | Endothelial Transcytosis of Insulin: Does It Contribute to Insulin Resistance? |
| Q51550693 | Excessive nicotinic acid increases methyl consumption and hydrogen peroxide generation in rats. |
| Q54393731 | Exercise and obesity-induced insulin resistance in skeletal muscle. |
| Q37176743 | Extrapancreatic effects of incretin hormones: evidence for weight-independent changes in morphological aspects and oxidative status in insulin-sensitive organs of the obese nondiabetic Zucker rat (ZFR). |
| Q89962538 | Fetal ovine skeletal and cardiac muscle transcriptomics are differentially altered by increased maternal cortisol during gestation |
| Q41812639 | Finding a Potential Dipeptidyl Peptidase-4 (DPP-4) Inhibitor for Type-2 Diabetes Treatment Based on Molecular Docking, Pharmacophore Generation, and Molecular Dynamics Simulation |
| Q33814873 | Genetic-epigenetic interactions in cis: a major focus in the post-GWAS era |
| Q28567664 | Genomic and metabolic responses to methionine-restricted and methionine-restricted, cysteine-supplemented diets in Fischer 344 rat inguinal adipose tissue, liver and quadriceps muscle |
| Q47821534 | Gestational Protein Restriction Impairs Glucose Disposal in the Gastrocnemius Muscles of Female Rats. |
| Q47890264 | Gestational Protein Restriction in Wistar Rats; Effect of Taurine Supplementation on Properties of Newborn Skeletal Muscle. |
| Q33901226 | Gestational protein restriction impairs insulin-regulated glucose transport mechanisms in gastrocnemius muscles of adult male offspring |
| Q90570276 | Glucose Uptake and Insulin Response in Tissue-engineered Human Skeletal Muscle |
| Q37368731 | Glucose-6-phosphate dehydrogenase contributes to the regulation of glucose uptake in skeletal muscle. |
| Q58114787 | Glucose-Mediated Glucose Disposal at Baseline Insulin is Impaired in IFG |
| Q34604686 | Guava leaf extracts promote glucose metabolism in SHRSP.Z-Leprfa/Izm rats by improving insulin resistance in skeletal muscle |
| Q33831849 | Gut microbiota, probiotics and diabetes. |
| Q58762736 | High Fat With High Sucrose Diet Leads to Obesity and Induces Myodegeneration |
| Q34871681 | High-fat diet feeding alters metabolic response to fasting/non fasting conditions. Effect on caveolin expression and insulin signalling. |
| Q26773988 | Hyperglycemic Stress and Carbon Stress in Diabetic Glucotoxicity |
| Q36628044 | Impaired glucose metabolism and exercise capacity with muscle-specific glycogen synthase 1 (gys1) deletion in adult mice |
| Q36279150 | Increased adipose protein carbonylation in human obesity |
| Q51103206 | Increased body fat mass and tissue lipotoxicity associated with ovariectomy or high-fat diet differentially affects bone and skeletal muscle metabolism in rats. |
| Q33646768 | Increased interaction with insulin receptor substrate 1, a novel abnormality in insulin resistance and type 2 diabetes. |
| Q41469912 | Insulin Control of Blood Glucose and GLUT4 Expression in the Skeletal Muscle of Septic Rats |
| Q48056892 | Insulin action in the brain: Roles in energy and glucose homeostasis |
| Q83452752 | Insulin resistance |
| Q42580599 | Insulin-dependent H2O2 production is higher in muscle fibers of mice fed with a high-fat diet |
| Q35620997 | Irisin and Myonectin Regulation in the Insulin Resistant Muscle: Implications to Adipose Tissue: Muscle Crosstalk |
| Q47755876 | Is It Time to Change the Type 2 Diabetes Treatment Paradigm? Yes! GLP-1 RAs Should Replace Metformin in the Type 2 Diabetes Algorithm. |
| Q38205763 | Knockout mouse models of insulin signaling: Relevance past and future |
| Q48246662 | Lipopolysaccharide inhibits hepatic gluconeogenesis in rats: The role of immune cells |
| Q41690998 | Liver Adiposity and Metabolic Profile in Individuals with Chronic Spinal Cord Injury. |
| Q34168368 | Liver and muscle in morbid obesity: the interplay of fatty liver and insulin resistance. |
| Q35927659 | Long-term high-fat-diet feeding induces skeletal muscle mitochondrial biogenesis in rats in a sex-dependent and muscle-type specific manner. |
| Q92854127 | Maternal Selenium Deficiency in Mice Alters Offspring Glucose Metabolism and Thyroid Status in a Sexually Dimorphic Manner |
| Q36184050 | Maternal moderate physical training during pregnancy attenuates the effects of a low-protein diet on the impaired secretion of insulin in rats: potential role for compensation of insulin resistance and preventing gestational diabetes mellitus |
| Q35744922 | Mechanisms Linking Inflammation to Insulin Resistance |
| Q28731457 | Metabolic control by S6 kinases depends on dietary lipids |
| Q26830631 | Metabolic disturbance in PCOS: clinical and molecular effects on skeletal muscle tissue |
| Q47235131 | Microbial Regulation of Glucose Metabolism and Insulin Resistance |
| Q39739679 | Mild Hyperbaric Oxygen Improves Decreased Oxidative Capacity of Spinal Motoneurons Innervating the Soleus Muscle of Rats with Type 2 Diabetes |
| Q41180449 | Mild Hyperbaric Oxygen Inhibits Growth-related Decrease in Muscle Oxidative Capacity of Rats with Metabolic Syndrome |
| Q38171425 | Mitochondria in metabolic disease: getting clues from proteomic studies. |
| Q96953430 | Mitochondrial Utilization of Competing Fuels Is Altered in Insulin Resistant Skeletal Muscle of Non-obese Rats (Goto-Kakizaki) |
| Q36320932 | Mitochondrial antioxidative capacity regulates muscle glucose uptake in the conscious mouse: effect of exercise and diet |
| Q35543642 | Mitochondrial dysfunction and insulin resistance from the outside in: extracellular matrix, the cytoskeleton, and mitochondria |
| Q36294297 | Molecular targets related to inflammation and insulin resistance and potential interventions |
| Q34878940 | Multiple implications of 3-phosphoinositide-dependent protein kinase 1 in human cancer. |
| Q36021653 | Muscular dystrophies at different ages: metabolic and endocrine alterations |
| Q42534113 | MyomiRs as Markers of Insulin Resistance and Decreased Myogenesis in Skeletal Muscle of Diet-Induced Obese Mice. |
| Q30008893 | Next-generation sequencing methylation profiling of subjects with obesity identifies novel gene changes |
| Q89624036 | Non-alcoholic fatty liver disease in lean individuals |
| Q64098845 | Overexpression of Long-Chain Acyl-CoA Synthetase 5 Increases Fatty Acid Oxidation and Free Radical Formation While Attenuating Insulin Signaling in Primary Human Skeletal Myotubes |
| Q37992232 | PTP1B and TCPTP--nonredundant phosphatases in insulin signaling and glucose homeostasis |
| Q35864829 | Pathobiochemical changes in diabetic skeletal muscle as revealed by mass-spectrometry-based proteomics |
| Q33849720 | Pathogenesis of chronic hyperglycemia: from reductive stress to oxidative stress |
| Q37845220 | Peripheral effects of the endocannabinoid system in energy homeostasis: adipose tissue, liver and skeletal muscle |
| Q36297299 | Phenolic compounds isolated from fermented blueberry juice decrease hepatocellular glucose output and enhance muscle glucose uptake in cultured murine and human cells |
| Q49117467 | Plasma carnosine, but not muscle carnosine, attenuates high-fat diet-induced metabolic stress |
| Q52745102 | Potential epigenetic biomarkers of obesity-related insulin resistance in human whole-blood. |
| Q48199112 | Potential of rooibos, its major C-glucosyl flavonoids, and Z-2-(β-D-glucopyranosyloxy)-3-phenylpropenoic acid in prevention of metabolic syndrome |
| Q34766541 | Pre- and early-postnatal nutrition modify gene and protein expressions of muscle energy metabolism markers and phospholipid Fatty Acid composition in a muscle type specific manner in sheep |
| Q37106937 | Prediabetes as a toxic environment for the initiation of microvascular and macrovascular complications |
| Q34718215 | Progesterone increases skeletal muscle mitochondrial H2O2 emission in nonmenopausal women |
| Q35653805 | Protein phosphatase 1 regulatory subunit 12A and catalytic subunit δ, new members in the phosphatidylinositide 3 kinase insulin-signaling pathway |
| Q34122700 | Proteomic analysis of gastrocnemius muscle in rats with streptozotocin-induced diabetes and chronically exposed to fluoride |
| Q34551875 | Proteomic analysis of skeletal muscle in insulin-resistant mice: response to 6-week aerobic exercise |
| Q36007826 | Proteomic analysis reveals cellular pathways regulating carbohydrate metabolism that are modulated in primary human skeletal muscle culture due to treatment with bioactives from Artemisia dracunculus L. |
| Q38980335 | Quantitative phosphoproteomics reveals novel phosphorylation events in insulin signaling regulated by protein phosphatase 1 regulatory subunit 12A. |
| Q54979343 | Rac1 muscle knockout exacerbates the detrimental effect of high-fat diet on insulin-stimulated muscle glucose uptake independently of Akt. |
| Q34110159 | Reduction in inflammatory gene expression in skeletal muscle from Roux-en-Y gastric bypass patients randomized to omentectomy |
| Q89983362 | Resveratrol alleviates obesity-induced skeletal muscle inflammation via decreasing M1 macrophage polarization and increasing the regulatory T cell population |
| Q49723467 | Revisiting the metabolic syndrome: the emerging role of aquaglyceroporins. |
| Q37724096 | Risk of postprandial insulin resistance: the liver/vagus rapport |
| Q38998401 | Role of AMP-Activated Protein Kinase for Regulating Post-exercise Insulin Sensitivity. |
| Q91121470 | Role of Complement and Complement-Related Adipokines in Regulation of Energy Metabolism and Fat Storage |
| Q24610857 | Role of nuclear receptor corepressor RIP140 in metabolic syndrome |
| Q27013026 | Roles of interstitial fluid pH in diabetes mellitus: Glycolysis and mitochondrial function |
| Q37163006 | SCD1 activity in muscle increases triglyceride PUFA content, exercise capacity, and PPARδ expression in mice |
| Q64059121 | SELENON (SEPN1) protects skeletal muscle from saturated fatty acid-induced ER stress and insulin resistance |
| Q47599401 | Sarcopenia is associated with an increased risk of advanced colorectal neoplasia |
| Q92662966 | Sarcopenic Obesity, Insulin Resistance, and Their Implications in Cardiovascular and Metabolic Consequences |
| Q38025166 | Second generation CB1 receptor blockers and other inhibitors of peripheral endocannabinoid overactivity and the rationale of their use against metabolic disorders |
| Q38436848 | Skeletal Muscle Vascular Function: A Counterbalance of Insulin Action. |
| Q102328552 | Skeletal muscle atrophy in heart failure with diabetes: from molecular mechanisms to clinical evidence |
| Q38261195 | Skeletal muscle glucose metabolism and inflammation in the development of the metabolic syndrome. |
| Q35128702 | Skeletal muscle proteomics: current approaches, technical challenges and emerging techniques |
| Q35088530 | Stem cells for skeletal muscle repair |
| Q28388533 | Sunflower oil supplementation has proinflammatory effects and does not reverse insulin resistance in obesity induced by high-fat diet in C57BL/6 mice |
| Q64903345 | Targeting ER stress/ER stress response in myopathies. |
| Q64255905 | Targeting the Zinc Transporter ZIP7 in the Treatment of Insulin Resistance and Type 2 Diabetes |
| Q92854149 | The Effects of Poncirus fructus on Insulin Resistance and the Macrophage-Mediated Inflammatory Response in High Fat Diet-Induced Obese Mice |
| Q89901290 | The Endothelial Barrier Is not Rate-limiting to Insulin Action in the Myocardium of Male Mice |
| Q45988896 | The FGF21 response to fructose predicts metabolic health and persists after bariatric surgery in obese humans. |
| Q29247855 | The Impact of Shiftwork on Skeletal Muscle Health |
| Q57810299 | The Proposal of Molecular Mechanisms of Weak Organic Acids Intake-Induced Improvement of Insulin Resistance in Diabetes Mellitus via Elevation of Interstitial Fluid pH |
| Q42803551 | The fatty acid-rich fraction of Eruca sativa (rocket salad) leaf extract exerts antidiabetic effects in cultured skeletal muscle, adipocytes and liver cells |
| Q33600053 | The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease |
| Q38328228 | The proteomic signature of insulin-resistant human skeletal muscle reveals increased glycolytic and decreased mitochondrial enzymes. |
| Q38040181 | The role of the endocannabinoid system in skeletal muscle and metabolic adaptations to exercise: potential implications for the treatment of obesity |
| Q40997556 | To explain the variation of OGTT dynamics by biological mechanisms: a novel approach based on principal components analysis in women with history of GDM. |
| Q38879146 | Toona Sinensis ameliorates insulin resistance via AMPK and PPARγ pathways |
| Q34504189 | Trace elements in glucometabolic disorders: an update |
| Q28395286 | Translating the basic knowledge of mitochondrial functions to metabolic therapy: role of L-carnitine |
| Q26783350 | Treatment of prediabetes |
| Q47913074 | VLDL and apolipoprotein CIII induce ER stress and inflammation and attenuate insulin signalling via Toll-like receptor 2 in mouse skeletal muscle cells. |
| Q89036802 | Voluntary exercise opposes insulin resistance of skeletal muscle glucose transport during liquid fructose ingestion in rats |
| Q38241464 | What are the pharmacotherapy options for treating prediabetes? |
| Q48159058 | Zinc stimulates glucose oxidation and glycemic control by modulating the insulin signaling pathway in human and mouse skeletal muscle cell lines |
| Q47127733 | Zinc transporters and insulin resistance: therapeutic implications for type 2 diabetes and metabolic disease. |
| Q35753755 | iTRAQ-based quantitative proteomic analysis of longissimus muscle from growing pigs with dietary supplementation of non-starch polysaccharide enzymes |
Search more.